OPXA Related New Coverage
-
Chardan Starts Opexa Therapeutics (OPXA) at Buy Following Efficacy Data for Tovaxin
-
Rodman & Renshaw Initiates Coverage on Opexa Therapeutucs (OPXA) with a Market Outperform
-
MDB Capital Starts Opexa Theraputics (OPXA) at Buy
Back to OPXA Stock Lookup
